As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
IPO Year:
Exchange: NASDAQ
Website: sabrahealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/17/2025 | Buy → Hold | Truist | |
| 1/7/2025 | $20.00 | Mkt Perform → Mkt Outperform | JMP Securities |
| 12/5/2024 | $20.00 | Outperform → Neutral | Mizuho |
| 10/1/2024 | $16.00 → $20.00 | Equal Weight → Overweight | Wells Fargo |
| 9/13/2024 | $17.00 → $20.00 | Neutral → Buy | Citigroup |
| 1/30/2024 | $21.00 | Buy | Deutsche Bank |
| 10/17/2023 | $16.00 | Outperform → Market Perform | BMO Capital Markets |
| 10/16/2023 | $13.00 → $15.00 | Underweight → Equal Weight | Wells Fargo |
| 10/10/2023 | $14.00 → $16.00 | Neutral → Buy | BofA Securities |
| 10/3/2023 | $16.00 | Outperform | Wedbush |
Truist downgraded Sabra Health Care REIT from Buy to Hold
JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00
Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00
Wells Fargo upgraded Sabra Health Care REIT from Equal Weight to Overweight and set a new price target of $20.00 from $16.00 previously
Citigroup upgraded Sabra Health Care REIT from Neutral to Buy and set a new price target of $20.00 from $17.00 previously
Deutsche Bank initiated coverage of Sabra Health Care REIT with a rating of Buy and set a new price target of $21.00
BMO Capital Markets downgraded Sabra Health Care REIT from Outperform to Market Perform and set a new price target of $16.00
Wells Fargo upgraded Sabra Health Care REIT from Underweight to Equal Weight and set a new price target of $15.00 from $13.00 previously
BofA Securities upgraded Sabra Health Care REIT from Neutral to Buy and set a new price target of $16.00 from $14.00 previously
Wedbush initiated coverage of Sabra Health Care REIT with a rating of Outperform and set a new price target of $16.00